Botanix Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Botanix Pharmaceuticals has a total shareholder equity of A$108.7M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$112.5M and A$3.7M respectively.
Key information
0%
Debt to equity ratio
AU$0
Debt
| Interest coverage ratio | n/a |
| Cash | AU$79.31m |
| Equity | AU$108.73m |
| Total liabilities | AU$3.73m |
| Total assets | AU$112.46m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BOT's short term assets (A$82.9M) exceed its short term liabilities (A$3.7M).
Long Term Liabilities: BOT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BOT is debt free.
Reducing Debt: BOT has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BOT has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BOT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.